Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
The Journal of Biological Chemistry
|
September 25, 1993
Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3
A W Norman, R Bouillon, M C Farach-Carson, et al.
Blood
|
July 1, 1991
Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism
J Y Zhou, A W Norman, M Akashi, et al.
Journal of Medicinal Chemistry
|
July 14, 2000
Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions
A W Norman, P S Manchand, M R Uskokovic, et al.
Bone
|
May 13, 1999
Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed
M L Siu-Caldera, H Sekimoto, A Weiskopf, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
January 1, 1996
Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report
A W Norman, J E Bishop, E D Collins, et al.
Molecular Endocrinology (Baltimore, Md.)
|
September 1, 1997
Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses
A W Norman, W H Okamura, M W Hammond, et al.
Clinical Endocrinology
|
January 1, 1976
The chemistry and conformational and biological analysis of vitamin D3, its metabolites and analogues
A W Norman, R L Johnson, T W Osborn, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
The Journal of Biological Chemistry
|
September 25, 1993
Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3
A W Norman, R Bouillon, M C Farach-Carson, et al.
Blood
|
July 1, 1991
Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism
J Y Zhou, A W Norman, M Akashi, et al.
Journal of Medicinal Chemistry
|
July 14, 2000
Characterization of a novel analogue of 1alpha,25(OH)(2)-vitamin D(3) with two side chains: interaction with its nuclear receptor and cellular actions
A W Norman, P S Manchand, M R Uskokovic, et al.
Bone
|
May 13, 1999
Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed
M L Siu-Caldera, H Sekimoto, A Weiskopf, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
January 1, 1996
Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report
A W Norman, J E Bishop, E D Collins, et al.
Molecular Endocrinology (Baltimore, Md.)
|
September 1, 1997
Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses
A W Norman, W H Okamura, M W Hammond, et al.
Clinical Endocrinology
|
January 1, 1976
The chemistry and conformational and biological analysis of vitamin D3, its metabolites and analogues
A W Norman, R L Johnson, T W Osborn, et al.
Page
of 6